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Abstract: Post-translational modifications such as phosphorylation are known to play 
an important role in the gene regulation by the transcription factors including the nuclear 
hormone receptor superfamily of which the glucocorticoid receptor (GR) is a member. Protein 
phosphorylation often switches cellular activity from one state to another. Like many other 
transcription factors, the GR is a phosphoprotein, and phosphorylation plays an important 
role in the regulation of GR activity. Cell signaling pathways that regulate phosphorylation of 
the GR and its associated proteins are important determinants of GR function under various 
physiological conditions. While the role of many phosphorylation sites in the GR is still not 
fully understood, the role of others is clearer. Several aspects of transcription factor function, 
including DNA binding afﬁ  nity, interaction of transactivation domains with the transcription 
initiation complex, and shuttling between the cytoplasmic compartments, have all been linked 
to site-speciﬁ  c phosphorylation. All major phosphorylation sites in the human GR are located 
in the N-terminal domain including the major transactivation domain, AF1. Available literature 
clearly indicates that many of these potential phosphorylation sites are substrates for multiple 
kinases, suggesting the potential for a very complex regulatory network. Phosphorylated GR 
interacts favorably with critical coregulatory proteins and subsequently enhances transcriptional 
activity. In addition, the activities and speciﬁ  cities of coregulators may be subject to similar 
regulation by phosphorylation. Regulation of the GR activity due to phosphorylation appears to 
be site-speciﬁ  c and dependent upon speciﬁ  c cell signaling cascade. Taken together, site-speciﬁ  c 
phosphorylation and related kinase pathways play an important role in the action of the GR, and 
more precise mechanistic information will lead to fuller understanding of the complex nature 
of gene regulation by the GR- and related transcription factors. This review provides currently 
available information regarding the role of GR phosphorylation in its action, and highlights the 
possible underlying mechanisms of action.
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coactivators
Introduction
The glucocorticoid receptor (GR) belongs to the superfamily of the hormone-activated 
intracellular transcription factors, the nuclear hormone receptors (NHRs). Most of the 
biological effects of glucocorticoids are mediated through the GR and occur at the 
level of regulation of gene transcription (Evans 1988; Beato 1989; Yamamoto 1985). 
The role of the GR, which acts in a ligand-, cell type-, and promoter-speciﬁ  c manner 
is important in the transcriptional activation of genes involving the regulated assembly 
of multiprotein complexes on enhancers and promoters (Simons 1994; Kumar et al 
1999a; Rogatsky et al 2003). The classical mechanism of steroid/hormone action 
(Figure 1) (Dean et al 1996; Kumar et al 1999b; Nissen et al 2000; Mendelson 2004) 
states that the GR in its inactive form is located in the cytoplasm, and after entry into Biologics: Targets & Therapy 2008:2(4) 846
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the cell the steroid/hormone ﬁ  nds the receptor as part of a 
large heteromeric complex consisting of several proteins 
including HSP90, HSP70, Immunophilins, FKBPs, CyP-40, 
P23, and possibly others (Housley et al 1985; Sanchez et al 
1987; Pratt et al 1997, 2003; Silverstein et al 1999; Shikama 
et al 2000; Davies et al 2002; Morishima et al 2003). Steroid 
binding leads to the disassembling of the complex through 
conformational changes in the receptor molecule and the 
activated receptor enters the nucleus, where it interacts with 
critical regulatory sites on the relevant genes (Hollenberg 
et al 1987; Orti et al 1992; Henriksson et al 1997; Horwitz 
et al 1996; Starr et al 1996; Lefstin et al 1998; Yamamoto et al 
1998; McKenna et al 1999; Kumar et al 2003; Rogatsky et al 
2003; Weigel et al 2007a, 2007b). The classic model for steroid 
action states that the DNA bound receptor collects a variety 
of ancillary factors which modify chromatin structure and/or 
contact the primary transcription complex machinery proteins 
such that transcription from the relevant promoter can be 
either enhanced or repressed. However, this has led to the 
problem of understanding how the receptor molecule makes 
such large protein surface areas available to accommodate 
speciﬁ  c sites for all these factors. The molecular mechanisms 
to explain this phenomenon have not been fully deﬁ  ned.
There are possibilities that some of these actions can be 
explained on the basis of post-translational modiﬁ  cations of 
speciﬁ  c NHRs. In spite of the fact that GR is a hormone-
activated transcription factor, its expression and many physi-
ological activities are highly regulated by post-translational 
modiﬁ  cations (Webster et al 1997; King et al 1998; Wallace 
et al 2001; Le Drean et al 2002; Tian et al 2002). One such 
important post-translational modiﬁ  cation associated with GR 
function is site-speciﬁ  c phosphorylation (Wang et al 2002; 
Ismaili et al 2004; Duma et al 2006). Involvement of several 
known phosphorylation sites in the GR and variety of kinases 
facilitates integration between cell-signaling pathways and 
the GR action (Krstic et al 1997; Rogatsky et al 1998a). 
Most, if not all known phosphorylation sites in the GR are 
localized within the N-terminal domain (NTD) that contains 
a major transactivation domain, AF1 (Bodwell et al 1991, 
1998; Blind et al 2004; Kumar et al 2004a).
Post-translational modiﬁ  cations including phosphoryla-
tion are generally an important phenomenon in regulation of 
protein function in eukaryotic cells, and are often concerned 
with switching of a cellular activity from one state to another 
(Auricchio 1989; Orti et al 1989; Kuiper et al 1994). It is 
now well accepted that for several transcription factors 
including GR, site-speciﬁ  c phosphorylation can modulate 
their DNA binding afﬁ  nity, the interaction of transactivation 
domains of these transcription factors with components of 
the transcription initiation complex, and the shuttling of 
transcription factors between the cytoplasmic compartments 
(Bai et al 1995; Rogatsky et al 1998b; Wang et al 1999; Gioeli 
et al 2002). There are several reports showing that kinases 
can phosphorylate GR at multiple sites leading to altered 
GR activity (Blind et al 2004; Ismaili et al 2004). Depending 
upon the kinases involved, the GR activity can be both up- or 
down-regulated (Ismaili et al 2004). For example, phosphory-
lation of GR by cyclin-dependent kinases (Cdk1, Cdk2, and 
cdk5) leads to up regulate GR activity (Ismaili et al 2004; 
Weigel et al 2007a), whereas JNK and GSK3 inhibits GR 
activity through direct phosphorylation of GR (Rogatsky et al 
1998a, 1998b). In contrast, certain kinases such as p38 MAPK 
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Figure 1 Classical action of the glucocorticoid signaling mediated by the GR. Unliganded receptor is located in the cytosol associated with several heat shock and other 
chaperone proteins including HSP90, HSP70, CyP-40, P23, and FKBPs (shown by different shapes and shades in the cytosol). Ligand binding leads to conformational alterations in 
the GR, and by doing so GR dissociates from these associated proteins, and ligand bound GR is free to translocate to the nucleus. This process appears to be phosphorylation-
dependent. Once in the nucleus, GR dimerizes and binds to site-speciﬁ  c DNA binding sequences and interacts with several other coregulatory proteins including coactivators 
and proteins from the basal transcription machinery including SRCs, CBP/p300, DRIP/TRAP, TBP, GRIP1, and several others (shown by different shapes and shades) in the 
nucleus, and subsequently leading to transcriptional regulation.Biologics: Targets & Therapy 2008:2(4) 847
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are reported to both up- and down-regulate GR activity, these 
effects of p38 MAPK appears to be cell-speciﬁ  c (Szatmary 
et al 2004; Miller et al 2005).
Some of the GR phosphorylation sites are conserved 
across species, whereas others are unique to speciﬁ  c species 
(Ismaili et al 2004). Generally, GR phosphorylation is ligand-
dependent, which suggests that this may be a determinant of 
promoter speciﬁ  city, interaction with coregulatory proteins, 
and even GR stability (Webster et al 1997; Zhou et al 2005; 
Faus et al 2006). There are several kinases that phosphorylate 
the GR with the resultant phosphorylation enhancing GR 
transcriptional activity (Ismaili et al 2004). However, GR can 
also be phosphorylated in a ligand independent manner as 
well (Ismaili et al 2004, 2005). In fact, we have earlier shown 
that p38 MAPK can phosphorylate human GR fragment 
lacking the LBD, which enhances the transactivation activity 
of the GR and mediates GR-dependent apoptosis in cells 
transfected with this fragment (Miller et al 2005). We also 
found that p38 was activated probably through immediate 
upstream activators, MKK3 and MKK6, both speciﬁ  c to p38 
(Miller et al 2005). In addition, MKK4, whose best-known 
substrate is JNK, can also phosphorylate p38. In recent years, 
it is becoming clearer that many receptor phosphorylation 
sites are substrates for multiple kinases, suggesting towards 
potential for very complex regulatory patterns. In this review 
article, we have summarized knowledge regarding the role of 
GR phosphorylation in the regulation of receptor function, 
and the possible underlying mechanisms of action.
The structural arrangements 
of the glucocorticoid receptor (GR)
The GR protein consists of a domain structure arrangement, 
typical of the superfamily of the NHRs (Yamamoto 1985; 
Evans 1988; Beato 1989; Simons 1994; Kumar et al 1999). 
This modular conceptual framework has been useful, but it 
has become clear that there are certain limits to the domain. 
This fundamental domain model divides the primary sequence 
into NTD, DNA-binding domain (DBD) (Hard  et al 1990; 
Luisi et al 1991), and LBD with “activation function” (AF2) 
sub-domain that regulates transcription (Giguere et al 1986; 
Hollenberg et 1987; Bocquel et al 1989; Ikonen et al 1997; 
Metivier et al 2001; Bledsoe et al 2002). Ligand binding to 
the LBD results in conformational rearrangement of its AF2 
sub-domain (usually helix 12) such that its surfaces are avail-
able for interactions with speciﬁ  c coregulatory proteins 
through LXXLL motifs. The GR and several other recep-
tors in the family have long NTD (Kumar  et al 2003). In 
these is found another, potent transactivation domain, AF1 
(Godowski et al 1987; Miesfeld et al 1987). Cooperative 
binding and site speciﬁ  city combine for GR:GRE tethering 
allows receptor’s interaction with the transcription initiation 
complex, directly by interactions between AF1/AF2 and 
the complex, or indirectly through speciﬁ  c coregulators 
(Thompson et al 2003). To a ﬁ  rst approximation, this concep-
tual model is useful, but fails to explain several essential facts 
such as the role of post-transcriptional modiﬁ  cations, includ-
ing sumoylation, acetylation, and site-speciﬁ  c phosphory-
lation. Our recent data and available literature from other 
laboratories clearly indicate an important role of GR phos-
phorylation and involvement of speciﬁ  c kinases (Rogatsky 
et al 1998a; Ismaili et al 2004; Miller et al 2005). Other data 
suggests that intramolecular signaling occurs as well between 
the amino-terminal and LBD regions (Ikonen  et al 1997; 
Hittelman et al 1999; Tetel  et al 1999; Kumar et al 1999; 
Bommer et al 2002). To fully understand the mechanisms 
of action of the GR, we must understand the answer to the 
above mentioned fundamental questions.
Phosphorylation regulates
structure and functions of the GR
Like many other transcription factors, the GR is a 
phosphoprotein, which becomes hyperphosphorylated upon 
steroid binding, and it has been suggested that phosphoryla-
tion plays an important role in the regulation of GR activity 
(Ismaili et al 2004). Protein phosphorylation is generally 
an important regulatory mechanism for protein function in 
eukaryotic cells, and is often concerned with switching of a 
cellular activity from one state to another. Phosphorylation 
of the Pol II protein complex is correlated with the transition 
between transcriptional initiation and elongation (Nissen 
et al 2000; Pinhero et al 2004); thus phosphorylation may be 
involved in transcriptional regulation. In recent years, more 
and more evidence point towards the role of phosphorylation 
and other post-translational modiﬁ  cations in the gene expres-
sion and regulation of many transcription factors (Boyle et al 
1991; Nichols et al 1992; Wisniewski et al 1999).
Cellular kinases play a prominent regulator role for the 
NHR (Ismaili et al 2004). Ligand binding, nuclear transloca-
tions, modulation of binding to REs, receptor dimerization, 
and interaction with general transcription factors, have 
all been linked to phosphorylation (Ismaili et al 2004). It 
has been reported that kinases enhance the transactiva-
tion activity of several steroid receptors both in a ligand-
dependent and ligand-independent manner (Rogatsky et al 
1998b; Ismaili et al 2004). For transcription factors, three 
main mechanisms of regulation by phosphorylation can be Biologics: Targets & Therapy 2008:2(4) 848
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identiﬁ  ed; 1) the DNA binding afﬁ  nity of transcription factors 
can be modulated negatively or positively; 2) the interaction 
of transactivation domains of transcription factors with 
components of the transcription initiation complex can be 
affected; and 3) the shuttling of transcription factors between 
the cytoplasmic compartments can be inﬂ  uenced.
In the human GR ﬁ  ve serine residues (S113, S141, S203, 
S211, and S226) have been identiﬁ  ed (Ismaili et al 2004), 
whereas in the mouse GR there are eight phosphorylation 
residues identiﬁ  ed. In mice, seven of the 8 phosphorylation 
sites are at serine residues (S122, S150, S212, S220, S234, 
S315, and S412) and one at threonine (T159) (Bodwell  et al 
1991; Bodwell 1998; Rogatsky et al 1998a). All the known 
phosphorylation sites identiﬁ  ed in mouse GR are found in 
the NTD, in or near the AF1 domain (Mason et al 1993). 
Several kinases are reported to be involved in the phos-
phorylation of these sites, such as mitogen protein kinases 
(MAPK), cyclin-dependent kinase (CDK) (Krstic et al 1997), 
glycogen synthase kinase-3 (GSK-3), and c-Jun N-terminal 
kinases (JNK) (Rogatsky et al 1998a). Though, each of 
these kinases is reported to show distinct speciﬁ  cities for 
potential phosphorylation residues, full receptor activity 
may require synergistic effects of these kinases and their 
signaling cascades.
In the human GR AF1, major functionally important 
known phosphorylated residues are S203, S211, and S226 
(ure 2). At least two of these (S211 and S226) are thought to 
be important for transcriptional activity of the GR (Rogatsky 
et al 1998b; Ismaili et al 2004; Miller et al 2005). The use of 
site-speciﬁ  c antibodies has shown that S203 phosphorylation 
is involved in the GR translocation (Ismaili et al 2004). It 
has also shown that site-speciﬁ  c (S211) phosphorylation of 
the GR AF1 enhances its interaction with a protein from the 
DRIP/TRIP complex, and subsequently GR activity (Blind 
et al 2004; Ismaili et al 2004). These observations clearly 
suggest that site-speciﬁ  c phosphorylation in GR AF1 may 
regulate GR function, in an AF1-dependent manner. However, 
it is not yet known exactly how phosphorylation inﬂ  uences 
the structure and functions of the GR AF1.
The AF1 can act constitutively in the absence of LBD, and 
is quite active in stimulating transcription from simple pro-
moters containing cognate binding sites(s). Because GR AF1 
exists in intrinsically disordered conformation(s), advances 
in understanding its structure and functions have been slowed 
(Dahlman-Wright et al 1995; Baskakov et al 1999; Kumar et al 
2004b). It is known that for function AF1 interacts with speciﬁ  c 
coregulatory proteins such as CBP, TBP, TIF2, DRIP/TRAP, 
Ada among others, and the available data strongly suggest 
that AF1 must adopt an ordered conformation to optimize 
interactions and subsequent transcriptional activity (Kumar 
et al 2003). In recent years, it has become quite evident that 
eukaryotic genomes are highly enriched in intrinsically dis-
order proteins relative to prokaryotes, reﬂ  ecting the greater 
need for signaling and regulation in nucleated cells (Crivici 
et al 1995; Namba 2001; Dyson et al 2002; Iakoucheva et al 
2002; Tompa 2002; Romero et al 2004; Ward et al 2004; Liu 
et al 2006). These disordered protein regions/domains promote 
molecular recognition primarily through unique combination 
of high speciﬁ  city and low binding afﬁ  nity with their functional 
binding partners, recognize and bind a number of biological 
targets, and create propensity to form large interaction surfaces 
suitable for interactions with their speciﬁ  c binding partners 
(Crivici et al 1995; Namba 2001; Iakoucheva et al 2002; Dyson 
et al 2002; Tompa 2002; Romero et al 2004; Ward et al 2004; 
Liu et al 2006). We hypothesize that site-speciﬁ  c phosphoryla-
tion of the GR AF1 leads to changes in its conformations that 
are important for AF1’s interaction with other critical coregula-
tory proteins, and subsequent transcriptional activity.
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Figure 2 A topological diagram of the human GR (amino acids 1–777) showing its modular structure and known phosphorylation sites in it (based on ref. 38). Numbers on 
the bottom indicate amino acid positions of different functional domains. 1–420, NTD; 77–262, AF1; 421–481; DBD; and remaining C-terminal part, the LBD are shown. P 
denotes known phosphorylation sites in the NTD of the human GR. Shown from left to right: S113, S141, S203, S211, S226, and S308. Corresponding amino acids in the rat 
GR are S134, S162, S224, S232, S246, and S329, whereas in the mouse GR these correspond to S122, S150, S212, S220, S234, and S315. In the rat and mouse GR, there is one 
Threonine residue (T171 in rat and T159 in mouse) that is known to be phosphorylable, and is not conserved in the human GR. In the human GR except for S308, all other 
residues are located within the AF1 domain, and S203, S211, and S226 are reported to have to have some functional roles in the action of the GR. Phosphorylation of these 
sites are kinase- and cell-dependent.Biologics: Targets & Therapy 2008:2(4) 849
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There are also reports suggesting that phosphorylation 
may affect GR stability and thus alter transcriptional activ-
ity of the receptor (Zhou et al 2005). Co-transfection data 
from Cidlowski and colleagues (Webster et al 1997; Wallace 
et al  2001) have shown that phosphorylated mouse GR 
had a half-life of 8–9 h in the presence of agonist, whereas 
mutations of multiple GR phosphorylation sites increased 
its half-life to 32 h. All the GR phosphorylation sites that 
are conserved among human, mouse, and rat are located 
within the AF1 domain. Single mutations of these do not alter 
receptor activity in an MMTV-driven promoter-reporter con-
struct, but a GR lacking all ﬁ  ve sites that are well conserved 
in mouse, rat and human GR shows signiﬁ  cantly decreased 
activity (Almlof et al 1995). Our recent published data 
however show that p38 and ERK2 are potent kinases for 
in vitro phosphorylation of S211 (located in AF1 domain) 
on the human GR (Miller et al 2005). The mutant lacking 
a phosphorylatable amino acid at position 211 (S221A) 
was considerably less potent in inducing the AF1-medited, 
GRE-driven reporter gene, and GR-mediated apoptosis 
induced by dexamethasone (Miller et al 2005). Garabedian 
and colleagues (Rogatsky et al 1998b; Blind et al 2004; 
Ismaili et al 2004; Kino et al 2007; Wang et al 2007) have 
also demonstrated that site-speciﬁ  c phosphorylation in GR, 
particularly S211 and S226 play an important role in gene 
regulation by the GR, and AF1 appears to be a main player 
in this process. Thus, in contrast to earlier study that sug-
gested lack of speciﬁ  city of phosphorylation (Almlof et al 
1995), these more recent ﬁ  ndings clearly indicate the role of 
site-speciﬁ  c phosphorylation in AF1-mediated GR functions 
(Ismaili et al 2004; Miller et al 2005).
Role of phosphorylation in protein:
protein interactions involving
the GR and speciﬁ  c coregulators
In the conceptual model of a GR:coactivator complexes, the 
ligand-bound receptor recruits one or more coactivators, 
which subsequently results in the recruitment of additional 
coactivators to the assembly. The histone acetylation and 
methylation activities of various constituents of the coactivator 
complex facilitate the relaxation of the chromatin architecture 
at the target gene promoter, thereby enhancing transcriptional 
activation. Analogous arguments can be made for GR:core-
pressors complexes (Horwitz et al 1996; Yamamoto et al 
1998; McKenna et al 1999). The GR AF1 domain is known 
to play an important role in many of these interactions, via 
interaction with regions of the coactivator remote from the 
LXXLL motif (Kumar et al 2003). The ability of GR AF1 
to interact with components of the general transcriptional 
machinery or with coregulator complexes provides a broad 
insight into the process of transcriptional initiation. CBP, TBP, 
AdA2, DRIP150, TSG101, and several other co-regulators 
have been shown to bind to the GR AF1 (Kumar et al 2003; 
Ismaili et al 2004). Direct binding of TBP with AF1, raises the 
possibility that this GR domain somehow directly inﬂ  uences 
the transcriptional machinery. In vitro transcription studies 
indicated that the holo-GR acts to stabilize the pre-initiation 
complex (Horwitz et al 1996; Yamamoto et al 1998; McKenna 
et al 1999), though other mechanisms to control transcription 
have recently been reported (Glass et al 1997; Yamamoto et al 
1998; Fujita et al 2003; Loven et al 2003).
It has been reported that the interaction between the GR 
and TSG101 may be modulated through GR phosphorylation 
(Ismaili et al 2005). This study shows that TSG101 is 
preferentially recruited to the nonphosphorylated form of 
the GR (Ismaili et al 2005). Another GR AF1 coregulator 
DRIP150 is also been reported to be modulated through GR 
phosphorylation (Ismaili et al 2004). Our unpublished data 
(Garza and Kumar, in preparation) show that interaction 
of several GR AF1 coregulators including TBP, CBP, and 
SRC-1 are facilitated by GR phosphorylation. Moreover, 
phosphorylation of several transcription factors, includ-
ing NHRs enhances recruitment of coregulatory proteins 
(Wu  et al 2005). Thus, it can be concluded that site-speciﬁ  c 
phosphorylation of the AF1 domain of GR can either enhance 
or diminish recruitment of coregulators.
These contrasting effects of AF1/GR phosphorylation on 
recruitment of speciﬁ  c coregulators may reﬂ  ect the biologic 
need for the GR to up- or down-regulate gene(s) in a cell- and 
promoter-speciﬁ  c manner. Recent studies have shown that GR 
site-speciﬁ  c phosphorylation can differentially regulate the 
expression of several target genes (Chen et al 2008; Davies 
et al 2008; Blind et al 2008). However, this phenomenon 
is not clearly understood, and further studies are needed to 
provide a more comprehensive explanation for this behavior. 
One clue to the complexity of this system is that SG101 sta-
bilizes ligand-unbound GR in its unphosphorylated form to 
protect it from degradation. Our recent ﬁ  ndings (Garza and 
Kumar, in preparation) suggest that phosphorylation of the 
GR stabilizes the conformation of otherwise unstructured 
AF1 such that AF1’s surfaces are available for its interaction 
with co-regulatory proteins. Thus, TSG101 interaction with 
GR may be important to keep unliganded GR protected from 
autodegradation until the GR becomes phosphorylated.
Recent studies suggest that in addition to the receptor 
phosphorylation, the activities and speciﬁ  cities of coregulators Biologics: Targets & Therapy 2008:2(4) 850
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are also subject to similar regulation by phosphorylation. For 
example, the actions of coregulators including SRCs and CBP 
can be modiﬁ  ed by phosphorylation (Tzukerman  et al 1994; 
Chen et al 1999; Font de Mora et al 2000; Rowan et al 2000a; 
Lopez et al 2001; See et al 2001; Puigserver  et al  2001; Yang 
et al 2001; Chevillard-Briet  et al 2002; Kotaja et al 2002; 
Chauchereau et al 2003; Wu et al 2005). Several phosphoryla-
tion sites for SRC-1 and SRC-3 have recently been identiﬁ  ed 
(Rowan et al 2000b; Wu et al 2004). Phosphorylation of these 
coregulators is induced by steroid hormones (Lopez et al 
2001; Wu et al 2004, 2005), and phosphorylation is critical 
for optimal activities. These data suggest that phosphory-
lation of coregulators may inﬂ  uence their protein-protein 
interactions with GR. This concept raised the possibility that 
the phosphorylation patterns of speciﬁ  c coregulator(s) might 
serve as a signal integrator, permitting this complex network 
of GR and cofactors to accurately and speciﬁ  cally activate a 
broad range of promoters for transcriptional activation.
Role of phosphorylation 
on the transactivation activity  
of the GR
It has been demonstrated that the status of GR phosphorylation 
can alter its transcriptional activity (Mason et al 1993). 
There are reports showing that in human GR S203A and/or 
S211A mutations signiﬁ  cantly repress GR activity, whereas 
S226A mutation has increased GR activity in a yeast system 
(Almlof et al 1995), suggesting that effects of phosphoryla-
tion on the GR transcriptional activity could be both up- or 
down-regulated depending upon the site of phosphorylation, 
and (due to site-speciﬁ  city of the kinase) probably the spe-
ciﬁ  c kinase pathways involved (Ismaili et al 2004). Reduced 
GR activity and decreased level of phosphorylation status 
have been observed in cells deﬁ  cient in the CDK inhibitor 
p27 (Rogatski et al 1997). However, other studies show that 
mutations of multiple GR phosphorylation sites do not sig-
niﬁ  cantly alter GRE-mediated GR activity in cell co-transfec-
tion studies (Almlof et al 1991). A number of explanations 
for these apparently conﬂ  icting results exist. For example, 
some studies were conducted using different promoters, and 
therefore it is quite possible that the inﬂ  uence of the GR 
phosphorylation on its transcriptional activation activity may 
be dependent on the promoter context of the target gene. It 
is also likely that site-speciﬁ  c phosphorylation of the GR 
would contribute to endogenous gene regulation, acting in a 
cell-type speciﬁ  c manner in which the use of kinases might 
differ (Zhou et al 2005). Another possible explanation is that 
individual phosphorylation sites may inﬂ  uence translocation 
to the nucleus (Webster et al 1997). However, the presence of 
conﬂ  icting data (Wang et al 2007) highlights the complexity 
of this system, and the need for more studies to establish 
underlying mechanisms.
We have shown that a mutation of Ser211 to Ala 
residue reduced GR-mediated transcriptional activation and 
apoptosis in a human leukemia cell line, suggesting a role 
for p38 MAPK signaling in glucocorticoid-induced apoptosis 
of lymphoid cells. With respect to the consequences of p38 
MAPK phosphorylation, it has further been shown that S211 
residue of AF1 is a speciﬁ  c substrate site for p38 MAPK, and 
that mutation S211A, which prevents phosphorylation at this 
position, diminishes apoptosis driven by the constitutively 
active GR lacking the ligand binding domain, suggesting a 
possible role of AF1-mediated GR transcriptional activity 
(Miller et al 2005). However, it is not known whether other 
phosphorylation sites (eg, S203 and S226) are also involved 
in this process. Further studies in our laboratory are exploring 
a variety of possibilities to understand the role of phosphory-
lation in GR function. Similar effects have been shown in 
other laboratories, using different cells and kinase pathways 
(Ismaili et al 2004). Thus, in contrast to earlier study (Almlof 
et al 1995), these recent ﬁ  ndings clearly indicate the critical 
role of site-speciﬁ  c phosphorylation of AF1 in regulating GR 
functions. Activity of steroid bound GR may also be reduced 
due to site-speciﬁ  c phosphorylation (Ismaili et al 2004). For 
example, activation of JNK induces rat GR phosphorylation 
at S246 which signiﬁ  cantly reduces GR activity; mutation of 
S246A, eliminating the potential phosphorylation site, dimin-
ishes inhibitory effects of JNK (Ismaili et al 2004). These 
results suggest that phosphorylation at S246 either increases 
its afﬁ  nity for a corepressor or decreases its interaction with 
a coactivator. Thus, site-speciﬁ  c phosphorylation and the 
particular kinase pathways involved in different cell types 
may dictate the pattern of GR regulation of speciﬁ  c target 
gene(s). Further, these effects may be synergistic in nature.
Additional studies are needed to clarify the underlying 
mechanisms to determine these effects. A possible role of 
phosphatases has also been reported to regulate GR phos-
phorylation and its subsequent effects of the transcriptional 
activity (Ismaili et al 2004). Perturbations in protein phos-
phatase activity have been shown to affect GR function. 
Treatment of cells with protein phosphatase inhibitor results 
in enhanced phosphorylation of GR, accumulation of GR 
in the cytoplasm, and subsequent reduction in GR-mediated 
transcriptional activation (DeFranco et al 1991; Sommers et al 
1992). However, the effects of speciﬁ  c phosphatases (and by 
extension speciﬁ  c phosphatase inhibitor) on site-speciﬁ  c GR Biologics: Targets & Therapy 2008:2(4) 851
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phosphorylation and function have not been well established. 
Collectively, the effect of phosphatases on GR signaling 
and transcriptional regulation is complex, and requires fur-
ther examination. Thus, it becomes of great importance to 
determine the pattern, kinetics, extent, and effects of phos-
phorylation/dephosphorylation in modulating GR action. 
Subsequently, it will be critical to establish the mechanisms 
by which modulation of GR activity occurs, and determine 
whether AF1 phosphorylation, in a site-speciﬁ  c manner, is an 
integrating phenomenon for GR regulation. Although short 
of actual proof, it seems apparent that both kinases and phos-
phatases may be interacting in complex ways to determine 
phosphorylation of speciﬁ  c sites within the GR AF1 that may 
well be cell- and promoter-speciﬁ  c in nature.
Summary and perspectives
Steroids have been frontline therapy for decades in the 
treatment of malignancies and inflammatory disorders; 
however the mechanism by which steroid receptors pass 
signals from ligand to regulate speciﬁ  c genes is not fully 
understood. Recent progress combined with classical under-
standing of the steroid receptors action, and the availability 
of the structure of individual domains of several members 
of the NHR superfamily including the GR has provided 
new understanding of the function of the GR. Recent stud-
ies have suggested that under physiological conditions, 
there are many factors that inﬂ  uence the conformation of 
the GR such that malleable protein surfaces are available 
for interaction with appropriate coactivators/corepressors. 
However, it remains to be determined how precisely these 
GR:protein interactions may differ with different cell- and 
promoter-speciﬁ  c conditions, and how the receptor com-
municates with transcription initiation machinery. Another 
important problem that remains to be solved is the precise 
mechanism by which AF1 and AF2 synergize with each 
other in the holo-receptor. Post-translational modiﬁ  cations 
including phosphorylation, ubiquitination, and sumoylation 
have all been shown to affect functions of NHR family 
members.
In recent years it has become clear that the cross-talk 
exists between GR signaling and other receptor cascades 
including inﬂ  ammatory kinases (MAPKs, ERK, p38 and 
JNK) as well as the cAMP-driven PKA pathways. There 
is evidence that that differential phosphorylation is a 
potential regulator of species-speciﬁ  c actions of the GR. 
However, current knowledge reveals that the role of GR 
phosphorylation is a remarkably complex phenomenon. It 
is evident that the GR is a target for multiple kinases, and 
that many GR functions are regulated by phosphorylation. 
Several outstanding questions remain to be answered. For 
example: 1) what are the relative levels of phosphorylation 
of individual sites under physiological conditions; 2) how do 
phosphatases inﬂ  uence the cellular machinery; and 3)  what is 
the correlation between cell based studies and in vivo animal 
models. However, it is clear that GR-mediated glucocorticoid 
signaling is a multifaceted process involving crosstalk with 
various regulatory kinase pathways. Thus, signaling cascades 
that induce phosphorylation of the GR and its coactivator 
proteins are critical factors in determining the physiological 
actions of the GR. Further studies that clarify the regulation of 
endogenous target genes by speciﬁ  c phosphorylation site(s) 
should lead to target- and perhaps tissue-speciﬁ  c require-
ments for phosphorylation. There are several other avenues 
of post-translational modiﬁ  cations that might also affect the 
actions of GR. Ubiquitination-mediated degradation regu-
lates glucocorticoid signaling by controlling the degradation 
rates of GR (Kinyamu et al 2005). Another post-translational 
modiﬁ  cation, sumoylation, can also regulate the GR func-
tions (Le Drean et al 2002). There are at least three known 
sumoylation sites in the human GR. Two of them are located 
in the NTD (K277 and K293) and one (K703) in the LBD 
(Faus et al 2006). Acetylation and methylation are other pos-
sible modiﬁ  cations that may inﬂ  uence GR actions; however, 
there is not enough evidence to suggest their direct role in 
modulating GR functions. At least one recent study has 
shown a ligand-dependent acetylation of the human GR at 
K494 and K495 residues, but the functional consequences 
of this modiﬁ  cation are not clear (Ito et al 2006).
We propose that under physiological conditions, 
site-speciﬁ  c phosphorylation plays a crucial role in allowing 
the AF1 domain of the GR to adopt functionally active 
conformation(s) in vivo (Figure 3). The resulting structurally 
modiﬁ  ed forms of AF1 suit it for its varied interactions with 
other critical coregulatory proteins, and possibly additional 
modulations in receptor structure essential for gene regulation 
by the GR. These interactions give a set of functionally 
active folded structure to AF1 and form the basis for the 
multiprotein assemblies involved in GR-mediated regulation 
of transcription. How site-speciﬁ  c phosphorylation leads to 
such AF1 conformation(s) and what kind of functional folded 
conformation it adopts are open questions, and we and others 
have been pursuing answers to these long-standing problems. 
Knowledge of the conformational changes in AF1 and/or 
other domains/regions of the GR due to site-speciﬁ  c phos-
phorylation and subsequently gene regulation will lead to an 
understanding of the role of this important phenomenon in the Biologics: Targets & Therapy 2008:2(4) 852
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transcription process, information essential to understanding 
how glucocorticoids affect gene regulation.
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